Biotype GmbH

https://www.biotype.de

BIOTYPE develops, produces and distributes molecular and in vitro diagnostic kits, systems and services for the detection and quantification of RNA and DNA markers within the Group. The tests support diagnosis and therapy in oncology, hemato-oncology, and DNA analysis in forensics. As a specialized Contract Development and Manufacturing Organization (CDMO), Biotype helps other companies overcome their challenges in bringing new molecular diagnostic products to market. BIOTYPE distributes products throughout Europe through its own distribution network and is currently expanding internationally. *

	Start	2019-06-13 merged
	Group	Molecular Diagnostics Group (MDG, family of Wilhelm Zörgiebel) (Group)
	Predecessor	Biotype Innovation GmbH
	Industry	molecular diagnostics
	Industry 2	companion diagnostic test
	Person	Zörgiebel, Wilhelm (Willi) (Biotype Diagnostic 201107 Managing Director + Owner before Priontype)

	Region	Dresden
	Country	Germany
	Street	67 Moritzburger Weg
	City	01109 Dresden
	Tel	+49-351-8838-400
		Address record changed: 2022-09-17

Basic data	Employees	B: 11 to 50 (2015-06-26)

		* Document for »About Section«: MDG Molecular Diagnostics Group GmbH. (12/21/22). "Press Release: Molecular Diagnostics Group and Swiss 4D Lifetec AG Become Strategic Partners".

		Record changed: 2023-12-30

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Molecular Diagnostics Group (MDG, family of Wilhelm Zörgiebel) (Group)

[1] MDG Molecular Diagnostics Group GmbH. (12/21/22). "Press Release: Molecular Diagnostics Group and Swiss 4D Lifetec AG Become Strategic Partners"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]